TMZ treatment reduced the tumor size and induced O6-MetG accumulation in lower Me3-NFAT5 K668 expression GBM-35 tumors (Fig. 8c-e and Supplementary Fig. 12a–c). Here, NFAT5 is linked to neoplasm.